Benzinga | Aug 6, 2020 06:39AM EDT

HC Wainwright & Co. Maintains Buy on Atara Biotherapeutics, Raises Price Target to $26

HC Wainwright & Co. maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Buy and raises the price target from $25 to $26.